Why choose the pediatric cancer & blood disorders department at Riley?
The Pediatric Cancer & Blood Disorders Department at Riley at IU Health ranks nationally as a provider of care for children with cancer and blood disorders. Our department is affiliated with the Indiana University Health Melvin and Bren Simon Cancer Center.
Why choose Riley at IU Health?
That is why the physician-scientists at Riley at IU Health and Indiana University Health University Hospital focus on research and clinical trials. The Riley at IU Health system ranks nationally for cancer care with access to the newest and best treatment options available.
How many blood donations are collected worldwide each year?
About 118.4 million blood donations are collected worldwide. 40% of these are collected in high-income countries, home to 16 % of the world’s population. About 13 300 blood centres in 169 countries report collecting a total of 106 million donations. Collections at blood centres vary according to income group.
What are the who guidelines for blood screening?
WHO recommends that all blood donations should be screened for infections prior to use. Screening for HIV, hepatitis B, hepatitis C, and syphilis should be mandatory. Blood screening should be performed according to quality system requirements.
What is Riley at IU Health?
This multidisciplinary approach is what leads to consistent annual ranking of Riley at IU Health as a top center for pediatric cancer and blood disorder treatment.
What is the only pediatric health system in Indiana to offer car T cell therapy?
Riley at IU Health is the only pediatric health system in the state of Indiana to offer CAR-T cell therapy for children with acute lymphoblastic leukemia (ALL).
National Blood Policy and Organization
Blood Donors
- Types of blood donors
There are 3 types of blood donors: 1. voluntary unpaid 2. family/replacement 3. paid. An adequate and reliable supply of safe blood can be assured by a stable base of regular, voluntary, unpaid blood donors. These donors are also the safest group of donors as the prevalence of bloodborn…
Blood Screening
- Table 1. Prevalence of transfusion-transmissible infections in blood donations (Median, Interqua…
These differences reflect the variation in prevalence among population who are eligible to donate blood, the type of donors (such as voluntary unpaid blood donors from lower risk populations) and the effectiveness of the system of educating and selecting donors.
Blood Processing
- Blood collected in an anticoagulant can be stored and transfused to a patient in an unmodified state. This is known as ‘whole blood’ transfusion. However, blood can be used more effectively if it is processed into components, such as red cell concentrates, platelet concentrates, plasma and cryoprecipitate. In this way, it can meet the needs of more than one patient. The capacity to prov…
Clinical Use of Blood
- 128 countries have national guidelines on the appropriate clinical use of blood: 32 countries in the African region (74% of reporting countries in the region), 23 in the Americas (70%), 12 in the E...
- Transfusion committees are present in 48% of the hospitals performing transfusions: 62% in hospitals in high-income countries, 35% in upper-middle-income countries, 31 in lower-middl…
- 128 countries have national guidelines on the appropriate clinical use of blood: 32 countries in the African region (74% of reporting countries in the region), 23 in the Americas (70%), 12 in the E...
- Transfusion committees are present in 48% of the hospitals performing transfusions: 62% in hospitals in high-income countries, 35% in upper-middle-income countries, 31 in lower-middle-income countr...
- Systems for reporting adverse transfusion events are present in 55% of the hospitals performing transfusions: 74% in hospitals in high-income countries, 35% in upper-middle-income countries, 22% in...
- 49% of reporting countries have a haemovigilance system. The European region has the high…
Who Response
- The risk of transmission of serious infections, including HIV and hepatitis, through unsafe blood and chronic blood shortages brought global attention to the importance of blood safety and availability. With the goal of ensuring universal access to safe blood and blood products, WHO has been at the forefront to improve blood safety and availability, and recommends the followin…